Application of the 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease in a seronegative rheumatoid arthritis cohort. [PDF]
Codes-Méndez H +4 more
europepmc +1 more source
Differences in intracellular localisation of ANKH mutants that relate to mechanisms of calcium pyrophosphate deposition disease and craniometaphyseal dysplasia. [PDF]
Vijen S +7 more
europepmc +1 more source
Features Associated With Different Inflammatory Phenotypes of Calcium Pyrophosphate Deposition Disease: A Study Using Data From the International American College of Rheumatology/EULAR Calcium Pyrophosphate Deposition Classification Criteria Cohort. [PDF]
Pascart T +32 more
europepmc +1 more source
Fluorescence Differentiation of ATP-related Multiple Enzymatic Activities in Synovial Fluid as a Marker of Calcium Pyrophosphate Deposition Disease using Kyoto Green. [PDF]
Yongwattana N +5 more
europepmc +1 more source
Updated Treatment for Calcium Pyrophosphate Deposition Disease: An Insight. [PDF]
Iqbal SM, Qadir S, Aslam HM, Qadir MA.
europepmc +1 more source
Pseudogout or pseudolymphoma? Calcium pyrophosphate deposition disease of the cervical spine: a rare presentation and literature review. [PDF]
Turaga S +3 more
europepmc +1 more source
Related searches:
Pathogenesis of calcium pyrophosphate deposition disease
Best Practice and Research in Clinical Rheumatology, 2021Charlène J Williams, Ann K Rosenthal
exaly
Calcium pyrophosphate deposition (CPPD) disease – Treatment options
Best Practice and Research in Clinical Rheumatology, 2021John Stack, Geraldine M Mccarthy
exaly

